Björkhem-Bergman L - Search Results

1

The role of thioredoxin reductase activity in selenium-induced cytotoxicity.

Madeja Z, Sroka J, Nyström C, Björkhem-Bergman L, Nordman T, Damdimopoulos A, Nalvarte I, Eriksson LC, Spyrou G, Olsson JM, Björnstedt M. Madeja Z, et al. Biochem Pharmacol. 2005 Jun 15;69(12):1765-72. doi: 10.1016/j.bcp.2005.02.023. Biochem Pharmacol. 2005. PMID: 15935149

2

Drug-resistant human lung cancer cells are more sensitive to selenium cytotoxicity. Effects on thioredoxin reductase and glutathione reductase.

Björkhem-Bergman L, Jönsson K, Eriksson LC, Olsson JM, Lehmann S, Paul C, Björnstedt M. Björkhem-Bergman L, et al. Biochem Pharmacol. 2002 May 15;63(10):1875-84. doi: 10.1016/s0006-2952(02)00981-4. Biochem Pharmacol. 2002. PMID: 12034372

3

The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress.

Xia L, Nordman T, Olsson JM, Damdimopoulos A, Björkhem-Bergman L, Nalvarte I, Eriksson LC, Arnér ES, Spyrou G, Björnstedt M. Xia L, et al. J Biol Chem. 2003 Jan 24;278(4):2141-6. doi: 10.1074/jbc.M210456200. Epub 2002 Nov 14. J Biol Chem. 2003. PMID: 12435734 Free article.

4

Regeneration of the antioxidant ubiquinol by lipoamide dehydrogenase, thioredoxin reductase and glutathione reductase.

Nordman T, Xia L, Björkhem-Bergman L, Damdimopoulos A, Nalvarte I, Arnér ES, Spyrou G, Eriksson LC, Björnstedt M, Olsson JM. Nordman T, et al. Biofactors. 2003;18(1-4):45-50. doi: 10.1002/biof.5520180206. Biofactors. 2003. PMID: 14695919 Review.

5

Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system.

Jönsson-Videsäter K, Björkhem-Bergman L, Hossain A, Söderberg A, Eriksson LC, Paul C, Rosén A, Björnstedt M. Jönsson-Videsäter K, et al. Biochem Pharmacol. 2004 Feb 1;67(3):513-22. doi: 10.1016/j.bcp.2003.09.021. Biochem Pharmacol. 2004. PMID: 15037203

6

Selenium prevents tumor development in a rat model for chemical carcinogenesis.

Björkhem-Bergman L, Torndal UB, Eken S, Nyström C, Capitanio A, Larsen EH, Björnstedt M, Eriksson LC. Björkhem-Bergman L, et al. Carcinogenesis. 2005 Jan;26(1):125-31. doi: 10.1093/carcin/bgh290. Epub 2004 Sep 30. Carcinogenesis. 2005. PMID: 15459019

7

Mammalian thioredoxin reductase alters cytolytic activity of an antibacterial peptide.

Björkhem-Bergman L, Jönsson-Videsäter K, Paul C, Björnstedt M, Andersson M. Björkhem-Bergman L, et al. Peptides. 2004 Nov;25(11):1849-55. doi: 10.1016/j.peptides.2004.06.012. Peptides. 2004. PMID: 15501515

8

Lovastatin prevents carcinogenesis in a rat model for liver cancer. Effects of ubiquinone supplementation.

Björkhem-Bergman L, Acimovic J, Torndal UB, Parini P, Eriksson LC. Björkhem-Bergman L, et al. Anticancer Res. 2010 Apr;30(4):1105-12. Anticancer Res. 2010. PMID: 20530415

9

Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma.

Rohr-Udilova N, Sieghart W, Eferl R, Stoiber D, Björkhem-Bergman L, Eriksson LC, Stolze K, Hayden H, Keppler B, Sagmeister S, Grasl-Kraupp B, Schulte-Hermann R, Peck-Radosavljevic M. Rohr-Udilova N, et al. Hepatology. 2012 Apr;55(4):1112-21. doi: 10.1002/hep.24808. Hepatology. 2012. PMID: 22105228

10

Statins inhibit expression of thioredoxin reductase 1 in rat and human liver and reduce tumour development.

Skogastierna C, Johansson M, Parini P, Eriksson M, Eriksson LC, Ekström L, Björkhem-Bergman L. Skogastierna C, et al. Biochem Biophys Res Commun. 2012 Jan 20;417(3):1046-51. doi: 10.1016/j.bbrc.2011.12.091. Epub 2011 Dec 26. Biochem Biophys Res Commun. 2012. PMID: 22222370

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters